Department of Precision Medicine, University of Campania "Luigi Vanvitelli", via L. De Crecchio, 7, 80138 Naples, Italy.
IMEM-CNR, Parco Area delle Scienze 37/A, 43124 Parma, Italy.
Biosensors (Basel). 2023 Mar 12;13(3):373. doi: 10.3390/bios13030373.
Lab-on-a-chip (LOC) systems are miniaturized devices aimed to perform one or several analyses, normally carried out in a laboratory setting, on a single chip. LOC systems have a wide application range, including diagnosis and clinical biochemistry. In a clinical setting, LOC systems can be associated with the Point-of-Care Testing (POCT) definition. POCT circumvents several steps in central laboratory testing, including specimen transportation and processing, resulting in a faster turnaround time. Provider access to rapid test results allows for prompt medical decision making, which can lead to improved patient outcomes, operational efficiencies, patient satisfaction, and even cost savings. These features are particularly attractive for healthcare settings dealing with complicated patients, such as those affected by chronic kidney disease (CKD). CKD is a pathological condition characterized by progressive and irreversible structural or functional kidney impairment lasting for more than three months. The disease displays an unavoidable tendency to progress to End Stage Renal Disease (ESRD), thus requiring renal replacement therapy, usually dialysis, and transplant. Cardiovascular disease (CVD) is the major cause of death in CKD, with a cardiovascular risk ten times higher in these patients than the rate observed in healthy subjects. The gradual decline of the kidney leads to the accumulation of uremic solutes, with negative effect on organs, especially on the cardiovascular system. The possibility to monitor CKD patients by using non-invasive and low-cost approaches could give advantages both to the patient outcome and sanitary costs. Despite their numerous advantages, POCT application in CKD management is not very common, even if a number of devices aimed at monitoring the CKD have been demonstrated worldwide at the lab scale by basic studies (low Technology Readiness Level, TRL). The reasons are related to both technological and clinical aspects. In this review, the main technologies for the design of LOCs are reported, as well as the available POCT devices for CKD monitoring, with a special focus on the most recent reliable applications in this field. Moreover, the current challenges in design and applications of LOCs in the clinical setting are briefly discussed.
微流控芯片(LOC)系统是一种旨在对单个芯片上进行一项或多项分析的微型化设备,这些分析通常在实验室环境中进行。LOC 系统的应用范围很广,包括诊断和临床生物化学。在临床环境中,LOC 系统可以与即时检测(POCT)的定义相关联。POCT 绕过了中心实验室检测的几个步骤,包括标本运输和处理,从而实现更快的周转时间。临床医生获得快速检测结果可以促使他们快速做出医疗决策,从而改善患者的治疗效果、提高运营效率、提升患者满意度甚至节省成本。这些特点对于处理复杂患者的医疗保健环境特别有吸引力,例如患有慢性肾病(CKD)的患者。CKD 是一种病理状况,其特征为持续和不可逆转的结构性或功能性肾损伤持续超过三个月。该疾病不可避免地会进展为终末期肾病(ESRD),因此需要肾脏替代治疗,通常是透析和移植。心血管疾病(CVD)是 CKD 患者死亡的主要原因,这些患者的心血管风险比健康人群高十倍。肾脏的逐渐衰竭会导致尿毒症溶质的积累,对器官产生负面影响,特别是对心血管系统。通过使用非侵入性和低成本的方法来监测 CKD 患者可能会给患者的治疗效果和卫生保健成本带来优势。尽管 POCT 具有许多优势,但在 CKD 管理中的应用并不常见,即使已经在全球范围内的实验室规模上通过基础研究(低技术就绪水平,TRL)证明了许多旨在监测 CKD 的设备。原因与技术和临床方面都有关。在这篇综述中,报告了用于 LOC 设计的主要技术,以及用于 CKD 监测的可用 POCT 设备,特别关注该领域的最新可靠应用。此外,还简要讨论了 LOC 在临床环境中的设计和应用目前面临的挑战。